Neutralizing antibodies to Omicron after the fourth SARS-CoV-2 mRNA vaccine dose in immunocompromised patients highlight the need of additional boosters https://www.medrxiv.org/content/10.1101/2022.11.19.22282537
Neutralizing antibodies to Omicron after the fourth SARS-CoV-2 mRNA vaccine dose in immunocompromised patients highlight the need of additional boosters https://www.medrxiv.org/content/10.1101/2022.11.19.22282537